smscall
logo
Pharma & Healthcare

Published On: Feb 10, 2025

Global Swine Vaccines Market Analysis and Forecast 2025-2031

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 205 Pages
  • 0 Views

Version Type

$4,950.00

Summary
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Swine Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Swine Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Swine Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Swine Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Swine Vaccines include Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.
Swine Vaccines Segment by Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Swine Vaccines Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Swine Vaccines Segment by Application
Government Tender
Market Sales
Swine Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Swine Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Table 1:Global Swine Vaccines Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031
Table 2:CSF Vaccines Major Manufacturers
Table 3:FMD Vaccines Major Manufacturers
Table 4:Porcine Circovirus Vaccines Major Manufacturers
Table 5:PRRS Vaccines Major Manufacturers
Table 6:Others Major Manufacturers
Table 7:Global Swine Vaccines Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031
Table 8:Government Tender Major Manufacturers
Table 9:Market Sales Major Manufacturers
Table 10:Swine Vaccines Industry Trends
Table 11:Swine Vaccines Industry Drivers
Table 12:Swine Vaccines Industry Opportunities and Challenges
Table 13:Swine Vaccines Industry Restraints
Table 14:Global Swine Vaccines Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 15:Global Swine Vaccines Revenue by Region (2020-2025) & (US$ Million)
Table 16:Global Swine Vaccines Revenue by Region (2026-2031) & (US$ Million)
Table 17:Global Swine Vaccines Revenue Market Share by Region (2020-2025)
Table 18:Global Swine Vaccines Revenue Market Share by Region (2026-2031)
Table 19:Global Swine Vaccines Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (M Doses)
Table 20:Global Swine Vaccines Sales by Region (2020-2025) & (M Doses)
Table 21:Global Swine Vaccines Sales by Region (2026-2031) & (M Doses)
Table 22:Global Swine Vaccines Sales Market Share by Region (2020-2025)
Table 23:Global Swine Vaccines Sales Market Share by Region (2026-2031)
Table 24:Global Swine Vaccines Revenue by Manufacturers (US$ Million) & (2020-2025)
Table 25:Global Swine Vaccines Revenue Market Share by Manufacturers (2020-2025)
Table 26:Global Swine Vaccines Sales by Manufacturers (US$ Million) & (2020-2025)
Table 27:Global Swine Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 28:Global Swine Vaccines Sales Price (USD/K Doses) of Manufacturers (2020-2025)
Table 29:Global Swine Vaccines Key Manufacturers Ranking, 2023 VS 2024 VS 2025
Table 30:Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 31:Global Swine Vaccines Manufacturers, Product Type & Application
Table 32:Global Swine Vaccines Manufacturers' Establishment Date
Table 33:Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34:Global Swine Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 35:Global Swine Vaccines Revenue by Type 2020 VS 2024 VS 2031 (US$ Million)
Table 36:Global Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 37:Global Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 38:Global Swine Vaccines Revenue Market Share by Type (2020-2025)
Table 39:Global Swine Vaccines Revenue Market Share by Type (2026-2031)
Table 40:Global Swine Vaccines Sales by Type 2020 VS 2024 VS 2031 (M Doses)
Table 41:Global Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 42:Global Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 43:Global Swine Vaccines Sales Market Share by Type (2020-2025)
Table 44:Global Swine Vaccines Sales Market Share by Type (2026-2031)
Table 45:Global Swine Vaccines Price by Type (2020-2025) & (USD/K Doses)
Table 46:Global Swine Vaccines Price by Type (2026-2031) & (USD/K Doses)
Table 47:Global Swine Vaccines Revenue by Application 2020 VS 2024 VS 2031 (US$ Million)
Table 48:Global Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 49:Global Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 50:Global Swine Vaccines Revenue Market Share by Application (2020-2025)
Table 51:Global Swine Vaccines Revenue Market Share by Application (2026-2031)
Table 52:Global Swine Vaccines Sales by Application 2020 VS 2024 VS 2031 (M Doses)
Table 53:Global Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 54:Global Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 55:Global Swine Vaccines Sales Market Share by Application (2020-2025)
Table 56:Global Swine Vaccines Sales Market Share by Application (2026-2031)
Table 57:Global Swine Vaccines Price by Application (2020-2025) & (USD/K Doses)
Table 58:Global Swine Vaccines Price by Application (2026-2031) & (USD/K Doses)
Table 59:Merck Company Information
Table 60:Merck Business Overview
Table 61:Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 62:Merck Swine Vaccines Product Portfolio
Table 63:Merck Recent Development
Table 64:Boehringer Ingelheim Company Information
Table 65:Boehringer Ingelheim Business Overview
Table 66:Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 67:Boehringer Ingelheim Swine Vaccines Product Portfolio
Table 68:Boehringer Ingelheim Recent Development
Table 69:Jinyu Bio-Technology Company Information
Table 70:Jinyu Bio-Technology Business Overview
Table 71:Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 72:Jinyu Bio-Technology Swine Vaccines Product Portfolio
Table 73:Jinyu Bio-Technology Recent Development
Table 74:CAHIC Company Information
Table 75:CAHIC Business Overview
Table 76:CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 77:CAHIC Swine Vaccines Product Portfolio
Table 78:CAHIC Recent Development
Table 79:Tecon Company Information
Table 80:Tecon Business Overview
Table 81:Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 82:Tecon Swine Vaccines Product Portfolio
Table 83:Tecon Recent Development
Table 84:Zoetis Company Information
Table 85:Zoetis Business Overview
Table 86:Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 87:Zoetis Swine Vaccines Product Portfolio
Table 88:Zoetis Recent Development
Table 89:Ceva Company Information
Table 90:Ceva Business Overview
Table 91:Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 92:Ceva Swine Vaccines Product Portfolio
Table 93:Ceva Recent Development
Table 94:Hile Bio Company Information
Table 95:Hile Bio Business Overview
Table 96:Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 97:Hile Bio Swine Vaccines Product Portfolio
Table 98:Hile Bio Recent Development
Table 99:Chopper Biology Company Information
Table 100:Chopper Biology Business Overview
Table 101:Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 102:Chopper Biology Swine Vaccines Product Portfolio
Table 103:Chopper Biology Recent Development
Table 104:WINSUN Company Information
Table 105:WINSUN Business Overview
Table 106:WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 107:WINSUN Swine Vaccines Product Portfolio
Table 108:WINSUN Recent Development
Table 109:Hipra Company Information
Table 110:Hipra Business Overview
Table 111:Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 112:Hipra Swine Vaccines Product Portfolio
Table 113:Hipra Recent Development
Table 114:Ringpu Biology Company Information
Table 115:Ringpu Biology Business Overview
Table 116:Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 117:Ringpu Biology Swine Vaccines Product Portfolio
Table 118:Ringpu Biology Recent Development
Table 119:ChengDu Tecbond Company Information
Table 120:ChengDu Tecbond Business Overview
Table 121:ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 122:ChengDu Tecbond Swine Vaccines Product Portfolio
Table 123:ChengDu Tecbond Recent Development
Table 124:DHN Company Information
Table 125:DHN Business Overview
Table 126:DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 127:DHN Swine Vaccines Product Portfolio
Table 128:DHN Recent Development
Table 129:CAVAC Company Information
Table 130:CAVAC Business Overview
Table 131:CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 132:CAVAC Swine Vaccines Product Portfolio
Table 133:CAVAC Recent Development
Table 134:Virbac Company Information
Table 135:Virbac Business Overview
Table 136:Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 137:Virbac Swine Vaccines Product Portfolio
Table 138:Virbac Recent Development
Table 139:HVRI Company Information
Table 140:HVRI Business Overview
Table 141:HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 142:HVRI Swine Vaccines Product Portfolio
Table 143:HVRI Recent Development
Table 144:Bioveta Company Information
Table 145:Bioveta Business Overview
Table 146:Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 147:Bioveta Swine Vaccines Product Portfolio
Table 148:Bioveta Recent Development
Table 149:North America Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 150:North America Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 151:North America Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 152:North America Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 153:North America Swine Vaccines Sales Price by Type (2020-2025) & (USD/K Doses)
Table 154:North America Swine Vaccines Sales Price by Type (2026-2031) & (USD/K Doses)
Table 155:North America Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 156:North America Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 157:North America Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 158:North America Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 159:North America Swine Vaccines Sales Price by Application (2020-2025) & (USD/K Doses)
Table 160:North America Swine Vaccines Sales Price by Application (2026-2031) & (USD/K Doses)
Table 161:North America Swine Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 162:North America Swine Vaccines Revenue Grow Rate by Country (2020-2025) & (US$ Million)
Table 163:North America Swine Vaccines Revenue Grow Rate by Country (2026-2031) & (US$ Million)
Table 164:North America Swine Vaccines Sales by Country (2020 VS 2024 VS 2031) & (M Doses)
Table 165:North America Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 166:North America Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 167:North America Swine Vaccines Sales Price by Country (2020-2025) & (USD/K Doses)
Table 168:North America Swine Vaccines Sales Price by Country (2026-2031) & (USD/K Doses)
Table 169:United States Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 170:Canada Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 171:Mexico Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 172:Europe Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 173:Europe Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 174:Europe Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 175:Europe Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 176:Europe Swine Vaccines Sales Price by Type (2020-2025) & (USD/K Doses)
Table 177:Europe Swine Vaccines Sales Price by Type (2026-2031) & (USD/K Doses)
Table 178:Europe Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 179:Europe Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 180:Europe Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 181:Europe Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 182:Europe Swine Vaccines Sales Price by Application (2020-2025) & (USD/K Doses)
Table 183:Europe Swine Vaccines Sales Price by Application (2026-2031) & (USD/K Doses)
Table 184:Europe Swine Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 185:Europe Swine Vaccines Revenue Grow Rate by Country (2020-2025) & (US$ Million)
Table 186:Europe Swine Vaccines Revenue Grow Rate by Country (2026-2031) & (US$ Million)
Table 187:Europe Swine Vaccines Sales by Country (2020 VS 2024 VS 2031) & (M Doses)
Table 188:Europe Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 189:Europe Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 190:Europe Swine Vaccines Sales Price by Country (2020-2025) & (USD/K Doses)
Table 191:Europe Swine Vaccines Sales Price by Country (2026-2031) & (USD/K Doses)
Table 192:Germany Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 193:France Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 194:U.K. Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 195:Italy Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 196:Russia Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 197:Spain Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 198:Netherlands Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 199:Switzerland Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 200:Sweden Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 201:Poland Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 202:China Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 203:China Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 204:China Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 205:China Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 206:China Swine Vaccines Sales Price by Type (2020-2025) & (USD/K Doses)
Table 207:China Swine Vaccines Sales Price by Type (2026-2031) & (USD/K Doses)
Table 208:China Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 209:China Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 210:China Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 211:China Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 212:China Swine Vaccines Sales Price by Application (2020-2025) & (USD/K Doses)
Table 213:China Swine Vaccines Sales Price by Application (2026-2031) & (USD/K Doses)
Table 214:Asia Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 215:Asia Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 216:Asia Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 217:Asia Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 218:Asia Swine Vaccines Sales Price by Type (2020-2025) & (USD/K Doses)
Table 219:Asia Swine Vaccines Sales Price by Type (2026-2031) & (USD/K Doses)
Table 220:Asia Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 221:Asia Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 222:Asia Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 223:Asia Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 224:Asia Swine Vaccines Sales Price by Application (2020-2025) & (USD/K Doses)
Table 225:Asia Swine Vaccines Sales Price by Application (2026-2031) & (USD/K Doses)
Table 226:Asia Swine Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 227:Asia Swine Vaccines Revenue Grow Rate by Country (2020-2025) & (US$ Million)
Table 228:Asia Swine Vaccines Revenue Grow Rate by Country (2026-2031) & (US$ Million)
Table 229:Asia Swine Vaccines Sales by Country (2020 VS 2024 VS 2031) & (M Doses)
Table 230:Asia Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 231:Asia Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 232:Asia Swine Vaccines Sales Price by Country (2020-2025) & (USD/K Doses)
Table 233:Asia Swine Vaccines Sales Price by Country (2026-2031) & (USD/K Doses)
Table 234:Japan Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 235:South Korea Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 236:India Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 237:Australia Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 238:Taiwan Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 239:Southeast Asia Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 240:SAMEA Swine Vaccines Revenue by Type (2020-2025) & (US$ Million)
Table 241:SAMEA Swine Vaccines Revenue by Type (2026-2031) & (US$ Million)
Table 242:SAMEA Swine Vaccines Sales by Type (2020-2025) & (M Doses)
Table 243:SAMEA Swine Vaccines Sales by Type (2026-2031) & (M Doses)
Table 244:SAMEA Swine Vaccines Sales Price by Type (2020-2025) & (USD/K Doses)
Table 245:SAMEA Swine Vaccines Sales Price by Type (2026-2031) & (USD/K Doses)
Table 246:SAMEA Swine Vaccines Revenue by Application (2020-2025) & (US$ Million)
Table 247:SAMEA Swine Vaccines Revenue by Application (2026-2031) & (US$ Million)
Table 248:SAMEA Swine Vaccines Sales by Application (2020-2025) & (M Doses)
Table 249:SAMEA Swine Vaccines Sales by Application (2026-2031) & (M Doses)
Table 250:SAMEA Swine Vaccines Sales Price by Application (2020-2025) & (USD/K Doses)
Table 251:SAMEA Swine Vaccines Sales Price by Application (2026-2031) & (USD/K Doses)
Table 252:SAMEA Swine Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031) & (US$ Million)
Table 253:SAMEA Swine Vaccines Revenue Grow Rate by Country (2020-2025) & (US$ Million)
Table 254:SAMEA Swine Vaccines Revenue Grow Rate by Country (2026-2031) & (US$ Million)
Table 255:SAMEA Swine Vaccines Sales by Country (2020 VS 2024 VS 2031) & (M Doses)
Table 256:SAMEA Swine Vaccines Sales by Country (2020-2025) & (M Doses)
Table 257:SAMEA Swine Vaccines Sales by Country (2026-2031) & (M Doses)
Table 258:SAMEA Swine Vaccines Sales Price by Country (2020-2025) & (USD/K Doses)
Table 259:SAMEA Swine Vaccines Sales Price by Country (2026-2031) & (USD/K Doses)
Table 260:Brazil Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 261:Argentina Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 262:Chile Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 263:Colombia Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 264:Peru Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 265:Saudi Arabia Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 266:Israel Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 267:UAE Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 268:Turkey Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 269:Iran Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 270:Egypt Swine Vaccines Revenue (2020-2031) & (US$ Million)
Table 271:Key Raw Materials
Table 272:Raw Materials Key Suppliers
Table 273:Swine Vaccines Distributors List
Table 274:Swine Vaccines Customers List
Table 275:Research Programs/Design for This Report
Table 276:Authors List of This Report
Table 277:Secondary Sources
Table 278:Primary Sources
Figure 1:Swine Vaccines Image
Figure 2:Global Swine Vaccines Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Swine Vaccines Market Size Share 2020 VS 2024 VS 2031
Figure 4:CSF Vaccines Image
Figure 5:FMD Vaccines Image
Figure 6:Porcine Circovirus Vaccines Image
Figure 7:PRRS Vaccines Image
Figure 8:Others Image
Figure 9:Global Swine Vaccines Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031
Figure 10:Global Swine Vaccines Market Size Share 2020 VS 2024 VS 2031
Figure 11:Government Tender Image
Figure 12:Market Sales Image
Figure 13:Global Swine Vaccines Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 14:Global Swine Vaccines Revenue (2020-2031) & (US$ Million)
Figure 15:Global Swine Vaccines Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16:Global Swine Vaccines Revenue Market Share by Region: 2024 Versus 2031
Figure 17:Global Swine Vaccines Revenue Market Share by Region (2020-2031)
Figure 18:Global Swine Vaccines Sales (2020-2031) & (M Doses)
Figure 19:Global Swine Vaccines Sales by Region: 2020 VS 2024 VS 2031 (M Doses)
Figure 20:Global Swine Vaccines Sales Market Share by Region (2020-2031)
Figure 21:US & Canada & Mexico Swine Vaccines Sales YoY (2020-2031) & (M Doses)
Figure 22:Europe Swine Vaccines Sales YoY (2020-2031) & (M Doses)
Figure 23:China Swine Vaccines Sales YoY (2020-2031) & (M Doses)
Figure 24:Asia (Excluding China) Swine Vaccines Sales YoY (2020-2031) & (M Doses)
Figure 25:South America, Middle East and Africa Swine Vaccines Sales YoY (2020-2031) & (M Doses)
Figure 26:Global Swine Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2024
Figure 27:Global Swine Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2024
Figure 28:Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29:Global Swine Vaccines Revenue by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 30:Global Swine Vaccines Revenue Market Share by Type 2020 VS 2024 VS 2031
Figure 31:Global Swine Vaccines Revenue Market Share by Type (2020-2031)
Figure 32:Global Swine Vaccines Sales by Type (2020 VS 2024 VS 2031) & (M Doses)
Figure 33:Global Swine Vaccines Sales Market Share by Type 2020 VS 2024 VS 2031
Figure 34:Global Swine Vaccines Sales Market Share by Type (2020-2031)
Figure 35:Global Swine Vaccines Revenue by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 36:Global Swine Vaccines Revenue Market Share by Application 2020 VS 2024 VS 2031
Figure 37:Global Swine Vaccines Revenue Market Share by Application (2020-2031)
Figure 38:Global Swine Vaccines Sales by Application (2020 VS 2024 VS 2031) & (M Doses)
Figure 39:Global Swine Vaccines Sales Market Share by Application 2020 VS 2024 VS 2031
Figure 40:Global Swine Vaccines Sales Market Share by Application (2020-2031)
Figure 41:North America Swine Vaccines Revenue Share by Type (2020-2031)
Figure 42:North America Swine Vaccines Sales Share by Type (2020-2031)
Figure 43:North America Swine Vaccines Revenue Share by Application (2020-2031)
Figure 44:North America Swine Vaccines Sales Share by Application (2020-2031)
Figure 45:North America Swine Vaccines Revenue Share by Country (2020-2031)
Figure 46:North America Swine Vaccines Sales Share by Country (2020-2031)
Figure 47:Europe Swine Vaccines Revenue Share by Type (2020-2031)
Figure 48:Europe Swine Vaccines Sales Share by Type (2020-2031)
Figure 49:Europe Swine Vaccines Revenue Share by Application (2020-2031)
Figure 50:Europe Swine Vaccines Sales Share by Application (2020-2031)
Figure 51:Europe Swine Vaccines Revenue Share by Country (2020-2031)
Figure 52:Europe Swine Vaccines Sales Share by Country (2020-2031)
Figure 53:China Swine Vaccines Revenue Share by Type (2020-2031)
Figure 54:China Swine Vaccines Sales Share by Type (2020-2031)
Figure 55:China Swine Vaccines Revenue Share by Application (2020-2031)
Figure 56:China Swine Vaccines Sales Share by Application (2020-2031)
Figure 57:Asia Swine Vaccines Revenue Share by Type (2020-2031)
Figure 58:Asia Swine Vaccines Sales Share by Type (2020-2031)
Figure 59:Asia Swine Vaccines Revenue Share by Application (2020-2031)
Figure 60:Asia Swine Vaccines Sales Share by Application (2020-2031)
Figure 61:Asia Swine Vaccines Revenue Share by Country (2020-2031)
Figure 62:Asia Swine Vaccines Sales Share by Country (2020-2031)
Figure 63:SAMEA Swine Vaccines Revenue Share by Type (2020-2031)
Figure 64:SAMEA Swine Vaccines Sales Share by Type (2020-2031)
Figure 65:SAMEA Swine Vaccines Revenue Share by Application (2020-2031)
Figure 66:SAMEA Swine Vaccines Sales Share by Application (2020-2031)
Figure 67:SAMEA Swine Vaccines Revenue Share by Country (2020-2031)
Figure 68:SAMEA Swine Vaccines Sales Share by Country (2020-2031)
Figure 69:Swine Vaccines Value Chain
Figure 70:Manufacturing Cost Structure
Figure 71:Swine Vaccines Production Mode & Process
Figure 72:Direct Comparison with Distribution Share
Figure 73:Distributors Profiles
Figure 74:Years Considered
Figure 75:Research Process
Figure 76:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Pharma & Healthcare

Global Swine Vaccines Market Analysis and Forecast 2025-2031

0| 0 Reviews

Pages: 205

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.